Skip to content

Study · Measured the body's own peptide · 2008

2 results

RF-Amide Neuropeptides in the Control of the Hypothalamo-Pituitary-Gonadal Axis

Curtis AE

Imperial College London1 Jan 2008

PepBankPUB-92721547
Source linkAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01LabEndogenous levelIn vitro (cells)Other

    In three human prostate cancer cell lines, all released the cells' own kisspeptin.

    In plain wordsIn lab tests, three human prostate cancer cell lines released the body's own kisspeptin.

    Peptide
    Kisspeptin-10
    Outcome
    Not applicableKisspeptin release by prostate cancer cell lines
    Study

    humann: not reported in source

    three human prostate cancer cell lines
    Outcome group
    Tumor growth · Cancer

    Source sentences

    Summary
    The role of kisspeptin in prostate cancer was investigated using three human prostate cancer cell lines, all of which were found to release kisspeptin.

    This result measures the body's own Kisspeptin-10. Nobody was given the peptide. It is not evidence about taking it.

Studies that did not test the peptide alone1

In this study, Kisspeptin-10 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Kisspeptin-10.

  1. 02AnimalNot a test of Kisspeptin-10 aloneOther designActivity measurement

    In vitro and in vivo studies identified the kisspeptin‑10 analogue ANA19, which stimulated the HPG axis for longer than kisspeptin‑10.

    In plain wordsIn lab and animal tests, a modified kisspeptin‑10, ANA19, stimulated the reproductive hormone axis for longer than kisspeptin‑10.

    Peptide
    Kisspeptin-10
    Outcome
    IncreaseHPG axis stimulation by analogue ANA19
    Study

    n: not reported in source

    Comparator
    Kisspeptin-10
    Outcome group
    Sex hormones and fertility · Endocrine and hormones

    Source sentences

    Summary
    In vitro and in vivo studies identified one analogue, ANA19, with a longer acting stimulatory effect on the HPG axis than kisspeptin-10.
    1 context sentence
    Summary · context
    I have designed 21 analogues of kisspeptin-10, and investigated their bioactivity in vitro and in vivo.

    In this study, Kisspeptin-10 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Kisspeptin-10.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.